Actualizado Reviewed

Appendix D: Key to Acronyms

General Terms

Acronym/Abbreviation Full Name
AASLD American Association for the Study of Liver Diseases
ACOG American College of Obstetricians and Gynecologists
ALT alanine aminotransferase
anti-HBc anti-hepatitis B core antibody
anti-HBS hepatitis B surface antibody
aOR adjusted odds ratio
aHR adjusted hazard ratio
aRR adjusted risk ratio
ART antiretroviral therapy
ARV antiretroviral
AUC area under the curve
AUC0-12h area under the curve from 0 to 12 hours 
BMC bone mineral content
BMD bone mineral density
BMI body mass index
BHIVA British HIV Association
C12h concentration at 12 hours postdose
C24h concentration at 24 hours postdose
CAR chimeric antigen receptor
CD4 CD4 T lymphocyte
CDC Centers for Disease Control and Prevention
CI confidence interval
Cmax maximum plasma concentration
Cmin minimum plasma concentration
Ctrough trough concentration
CNS central nervous system
CrCl creatinine clearance
CYP cytochrome P450
CYP3A4 cytochrome P450 3A4
DAA direct-acting antiviral
DBS dried blood spots
EC enteric coated
EC90 90% maximal effective concentration
ePPND enhanced Pre- and Postnatal Development
FDA U.S. Food and Drug Administration
FDC fixed-dose combination
GMC geometric mean concentration
gp glycoprotein
HAV hepatitis A virus
HBIG hepatitis B immune globulin
HBcAb hepatitis B core antibody
HBeAb hepatitis B e antibody
HBeAg hepatitis B e antigen
HbsAb hepatitis B surface antibody
HbsAg hepatitis B surface antigen
HBV hepatitis B virus
HCV hepatitis C virus
HCAZ head circumference–for–age z-scores
HEU HIV exposed but uninfected
HD high dose
HDP hypertensive disorders of pregnancy
HUU HIV unexposed and uninfected
HR hazard ratio
HRSA Health Resources and Services Administration
HSR hypersensitivity reaction
IC50 inhibitory concentration 50%
IGF insulin-like growth factor
IgG immunoglobulin G
IM intramuscular
INSTI integrase strand transfer inhibitor
IPV intimate partner violence
IQR interquartile range
IDSA Infectious Diseases Society of America
IUD intrauterine device
IUPC intrauterine pressure catheter
IV intravenous/intravenously
LARC long-acting reversible contraceptive
LAZ length-for-age z-scores
LBW low birth weight
mtDNA mitochondrial DNA
NAT nucleic acid test
NAT2 N-acetyltransferase 2
NHSS National HIV Surveillance System
NICHD National Institute of Child Health and Human Development
NIH National Institutes of Health
NNRTI non-nucleoside reverse transcriptase inhibitor/non-nucleoside analogue reverse transcriptase inhibitor
nPEP non-occupational post-exposure prophylaxis
NRTI nucleoside reverse transcriptase inhibitor/nucleoside analogue reverse transcriptase inhibitor
NTD neural tube defect
OARAC Office of AIDS Research Advisory Council
OI opportunistic infection
OR odds ratio
The Panel The Panel on Treatment of HIV in Pregnancy and Prevention of Perinatal Transmission
PBMC peripheral blood mononuclear cells
PBPK physiologically based pharmacokinetic
PJP Pneumocystis jirovecii pneumonia
PCR polymerase chain reaction
PI protease inhibitor
PK pharmacokinetic
PO orally
POC point of care
PPI proton pump inhibitor
PrEP pre-exposure prophylaxis
PTB preterm birth
RAM resistance-associated mutation
RCT randomized controlled trial
RDS respiratory distress syndrome
ROM rupture of membranes
RR relative risk
SGA small for gestational age
sPTB spontaneous preterm birth
STI sexually transmitted infection
t1/2app terminal-phase half-life
TB tuberculosis
Tdap tetanus, diphtheria and pertussis
TDM therapeutic drug monitoring
UGT uridine diphosphate glucuronosyltransferase
vPTB very preterm birth
VL viral load
vSGA very small for gestational age
WAZ weight-for-age z-scores
WHO World Health Organization

Download Guidelines